Loading data
MRDNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 182.86 m USD | 151.12 m USD | 92.99 m USD | 44.17 m USD | 36.03 m USD |
| Cost of revenue | 79.41 m USD | 62.54 m USD | 24.75 m USD | 34.31 m USD | 26.87 m USD |
| Gross profit | 103.46 m USD | 88.57 m USD | 68.24 m USD | 9.87 m USD | 9.16 m USD |
| Research and development expense | 7.1 m USD | 6.07 m USD | — | — | 23.09 k USD |
| Selling, general and administrative expense | 199.63 m USD | 85.83 m USD | 54.48 m USD | — | — |
| Operating profit | -96.17 m USD | 2.74 m USD | 13.76 m USD | -526.25 k USD | 192.49 k USD |
| Interest expense | 4.58 m USD | 3.52 m USD | 36.16 k USD | 12.4 k USD | 0 USD |
| Profit before tax | -97.19 m USD | 1.21 m USD | 15.47 m USD | -489.44 k USD | 463.08 k USD |
| Income tax expense | -5.21 m USD | 2.62 m USD | 1.57 m USD | 683.31 k USD | 419.05 k USD |
| Net income (reported basis) | -91.98 m USD | -1.41 m USD | 13.7 m USD | -1.17 m USD | 44.03 k USD |
| Net income attributable to common shareholders | -89.9 m USD | -1.48 m USD | 13.7 m USD | -1.17 m USD | -250.04 k USD |
| Basic earnings per share | -7.76 USD/share | -0.16 USD/share | 0.16 USD/share | -0.03 USD/share | -0.01 USD/share |
| Diluted earnings per share | -7.76 USD/share | -0.16 USD/share | 0.16 USD/share | -0.03 USD/share | -0.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.